Noga Fallach
YOU?
Author Swipe
View article: Impact of Universal Varicella Vaccination in Israel: A Time-series Analysis, 2003 to 2020
Impact of Universal Varicella Vaccination in Israel: A Time-series Analysis, 2003 to 2020 Open
Background: Two-dose universal varicella vaccination (UVV) was included in Israel’s national immunization program in 2008. We aimed to evaluate the impact of the UVV program on varicella incidence and healthcare costs in Israel. Methods: A…
View article: Outcomes and Healthcare Resource Utilization in Patients with COVID-19 Treated with Nirmatrelvir–Ritonavir: Real-World Data Analysis
Outcomes and Healthcare Resource Utilization in Patients with COVID-19 Treated with Nirmatrelvir–Ritonavir: Real-World Data Analysis Open
Background: Nirmatrelvir–ritonavir was granted emergency use authorization in Israel in January 2022 to treat high-risk patients with mild-to-moderate COVID-19. The aim of the study was to assess the association between nirmatrelvir–ritona…
View article: Hemolytic disease of fetus and newborn course, management and outcomes - an analysis based on the Israeli Maccabi database
Hemolytic disease of fetus and newborn course, management and outcomes - an analysis based on the Israeli Maccabi database Open
Objective: Hemolytic disease of the fetus and newborn (HDFN) can cause severe prenatal and postnatal outcomes. The main objective of this study is to understand the clinical impact of HDFN on pregnant women and newborns. Study Design: A re…
View article: Pregnancy outcomes after SARS-CoV-2 infection by trimester: A large, population-based cohort study
Pregnancy outcomes after SARS-CoV-2 infection by trimester: A large, population-based cohort study Open
Objectives Data regarding women infected with SARS-CoV-2 during early trimesters are scarce. We aimed to assess preterm birth (PTB) and small-for-gestational-age (SGA) rates in a large and unselected cohort by trimester at infection and ov…
View article: Describing COVID-19 Patients During The First Two Months of Paxlovid (Nirmatrelvir/Ritonavir) Initiation in a Large HMO in Israel
Describing COVID-19 Patients During The First Two Months of Paxlovid (Nirmatrelvir/Ritonavir) Initiation in a Large HMO in Israel Open
Title Describing COVID-19 Patients During The First Two Months of Paxlovid (Nirmatrelvir/Ritonavir) Initiation in a Large HMO in Israel Objective The objective of this feasibility study was to assess the number of patients that could be in…
View article: Prevalence and Incidence of Osteoarthritis: A Population-Based Retrospective Cohort Study
Prevalence and Incidence of Osteoarthritis: A Population-Based Retrospective Cohort Study Open
While trends data of osteoarthritis (OA) are accumulating, primarily from Western Europe and the US, a gap persists in the knowledge of OA epidemiology in Middle Eastern populations. This study aimed to explore the prevalence, incidence, c…
View article: Utilising sigmoid models to predict the spread of antimicrobial resistance at the country level
Utilising sigmoid models to predict the spread of antimicrobial resistance at the country level Open
Background The spread of antimicrobial resistance (AMR) is of worldwide concern. Public health policymakers and pharmaceutical companies pursuing antibiotic development require accurate predictions about the future spread of AMR. Aim We ai…
View article: Elderly bedridden patients with dementia use over one quarter of resources in internal medicine wards in an Israeli hospital
Elderly bedridden patients with dementia use over one quarter of resources in internal medicine wards in an Israeli hospital Open
Background Elderly bedridden patients with dementia (EBRPD) are a growing segment of the population. We aimed to describe acute care hospitalization of EBRPD in internal medicine wards: the prevalence of EBRPD, their impact on hospital res…
View article: Personalized Ertapenem Prophylaxis for Carriers of Extended-spectrum β-Lactamase–producing Enterobacteriaceae Undergoing Colorectal Surgery
Personalized Ertapenem Prophylaxis for Carriers of Extended-spectrum β-Lactamase–producing Enterobacteriaceae Undergoing Colorectal Surgery Open
Background Carriers of extended-spectrum β-lactamase–producing Enterobacteriaceae (ESBL-PE) who receive cephalosporin-based prophylaxis have twice the risk of surgical site infection (SSI) following colorectal surgery as noncarriers. We te…
View article: Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study
Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study Open
Innovative Medicines Initiative.
View article: The impact of antibiotic use on transmission of resistant bacteria in hospitals: Insights from an agent-based model
The impact of antibiotic use on transmission of resistant bacteria in hospitals: Insights from an agent-based model Open
Extensive antibiotic use over the years has led to the emergence and spread of antibiotic resistant bacteria (ARB). Antibiotic resistance poses a major threat to public health since for many infections antibiotic treatment is no longer eff…
View article: Blood Culture Sampling Practices among Internal Medicine Inpatients
Blood Culture Sampling Practices among Internal Medicine Inpatients Open
Objective: Blood cultures are essential for the diagnosis of bloodstream infections; however, they carry a risk of both low yield and culturing skin contaminants.The optimal culturing threshold which results in a high sensitivity of detect…
View article: Risk Factors for Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) Acquisition Among Contacts of Newly Diagnosed CP-CRE Patients
Risk Factors for Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) Acquisition Among Contacts of Newly Diagnosed CP-CRE Patients Open
OBJECTIVE Carbapenemase-producing carbapenem-resistant Enterobacteriaceae (CP-CRE) are extremely drug-resistant pathogens. Screening of contacts of newly identified CP-CRE patients is an important step to limit further transmission. We aim…
View article: Correction for Adler et al., Prevalence, Risk Factors, and Transmission Dynamics of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae: a National Survey of Cattle Farms in Israel in 2013
Correction for Adler et al., Prevalence, Risk Factors, and Transmission Dynamics of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae: a National Survey of Cattle Farms in Israel in 2013 Open
Volume 53, no. 11, p. [3515–3521][1], 2015. Page 3521: The following paragraph should be inserted at the end of the Acknowledgments section.
The study was funded in part by the Research Projects and Fellowships Fund on Food and Nutrition …